Abstract:OBJECTIVE:To explore the effect of micro ribonucleic acid (miRNA)-146a on kidney injury in mice with systemic lupus erythematosus (SLE), and to investigate its possible mechanism.MATERIALS AND METHODS:A total of 45 female MRL/lpr mice were randomly divided into control group, miR-146a mimic group and miR-146a inhibitor group. Urine protein level was measured every 2 weeks. Meanwhile, the levels of serum anti-dsdeoxyribonucleic acid (anti-dsDNA), anti-ssDNA, antinuclear antibody (ANA) and anti-chromatin were measured using enzyme-linked immunosorbent assay (ELISA). At 2 weeks after drug treatment, the effects of miR-146a mimic and inhibitor on kidney tissues of MRL/lpr mice were detected and analyzed by gene chip and gene set enrichment analysis, respectively. The mice were executed at the age of 24 weeks, and the blood samples were collected. Subsequently, the level of blood urea nitrogen (BUN) was measured using the BUN analyzer. After that, kidney tissues were taken, and the effect of drug treatment on the morphology of kidney tissues was detected via hematoxylin-eosin (HE) staining. Moreover, the effects of drug treatment on the mRNA levels of inflammatory factors and the nuclear factor-κB (NF-κB) signaling pathway in kidney tissues were detected via quantitative real-time polymerase chain reaction (qRT-PCR) and Western blotting, respectively.RESULTS:MiR-146a mimic significantly reduced urine protein in a time-dependent manner, which also significantly reduced BUN level at 24 weeks. The results of HE staining showed that both glomerular injury and renal vascular injury in miR-146a mimic group were significantly alleviated. In miR-146a mimic group, serum autoantibodies of anti-dsDNA, anti-ssDNA, anti-chromatin and ANA decreased significantly. However, the survival time of mice was significantly prolonged. High-throughput gene expression chip technique elucidated that in miR-146a mimic group, the expression of positive regulatory gene of NF-κB showed a decreasing trend. However, the expression of negative regulatory gene of NF-κB showed an increasing trend. MiR-146a mimic remarkably down-regulated the expression levels of RELA, IRAK1, interleukin-1B (IL1B) and IL-10 in kidney tissues. Furthermore, the results of Western blotting showed that miR-146a mimic inhibited both the classical and non-classical NF-κB signaling pathways.CONCLUSIONS:MiR-146a reduces SLE-induced kidney injury in MRL/lpr mice through regulating classical and non-classical NF-κB signaling pathways.

Influence of Specific Cyclooxygenase-2 Inhibitor on the Expression of Plasminogen Activator Inhibitor Type-1 in Lupus MRL/Ipr Mice

Influence of Specific Cyclooxygenase- 2 Inhibitor on TNF- Α, IL- 6 and Expression CD14 Positive Cells in Lupus MRL/lpr Mice

Protective Effects of Specific Cyclooxygenase-2 Inhibition in the Treatment of MRL/lpr Mice

Efficacy of mIL-18BP and mIL-4 adenoviral coexpression gene therapy for cyclooxygenase-2 and inducible nitric oxide synthetase in murine collagen-induced arthritis

Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease

Correlative Analysis Between Renal TGF-β1 Expression and Cell Apoptosis in a Rat Model of Cyclosporine-Induced Chronic Nephrotoxicity, and Effect of Tea Polyphenols on TGF-β1 Expression and Apoptosis

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II

A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects Against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/lpr Mice.

The Effect of Hydroxychloroquine Treatment on MRL/lpr Lupus Mice

Effect of selective COX-2 inhibitor and PGE1 on the expression of VEGF and CTGF in cirrhotic rats

MiR-146a Relieves Kidney Injury in Mice with Systemic Lupus Erythematosus Through Regulating NF-κB Pathway.

Comparison of renoprotective effect between angiotensin Ⅱ receptor antagonist and angiotensin converting enzyme inhibitor on puromycin nephropathy and their possible mechanism

Expression of Plasminogen Activator Inhibitor-1 in Kidney of Diabetic Rats and Its Modulation by Tongxinluo Capsule

Protective effect of indomethacin in renal ischemia-reperfusion injury in mice.

Effect of Cyclooxygenase-2 on Liver Fibrogenesis Induced by CCl4 in Rats

Valsantan on the expression of plasminogen activator inhibitor-1 in rats with glomerulosclerosis

P0704PROTECTIVE EFFECT OF DUAL ACTING LIGAND TARGETING A2A AND A3 ADENOSINE RECEPTOR ON OBSTRUCTION-INDUCED KIDNEY INJURY IN MICE

Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice

Cyclooxygenases (COX) Play a Key Role in the Regulation of Renal Arterial Tone, but Not in Glomerular Function,of Mouse with 5/6 Nephrectomy (LB725)

Periplaneta Americana Extract May Attenuate Renal Fibrosis through Inhibiting Janus Tyrosine Kinase 2/Signal Transducer and Activator of Transcription 3 Pathway

Effectiveness of a novel rat model of off-target PLA2R1 knockout to renal impairment